Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo

Diabetes

Volumn 48, Issue 10, 1999, Pages 2052-2058

  Bonnardel Phu, Evelyne ^a   Wautier, Jean Luc ^b   Schmidt, Ann Marie ^c   Avila, Cecilia ^c   Vicaut, Eric ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; ANTIBODY; FLUORESCEIN ISOTHIOCYANATE; PROBUCOL; RECOMBINANT RECEPTOR; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPUTER AIDED DESIGN; CONTROLLED STUDY; CREMASTER MUSCLE; DIABETIC MICROANGIOPATHY; EXTRAVASATION; GLYCATION; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ALBUMINS; ANIMALS; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CAPILLARY LEAK SYNDROME; DIABETES MELLITUS, EXPERIMENTAL; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; MICROCIRCULATION; PROBUCOL; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; RECOMBINANT PROTEINS;

EID: 0032861267     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.10.2052     Document Type: Article

References (38)

1. Viberti GC: Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. Am J. Med 75:81-84, 1983
2. Shostak A, Gotloib L: Increased peritoneal permeability to albumin in streptozotocin diabetic rats. Kidney Int 49:705-714, 1996
3. Williamson JR, Chang K, Tilton RG, Prater C, Jeffrey JR, Weigel C, Sherman WR, Eades DM, Kilo C: Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Diabetes 36:813-821, 1987
4. Alpert JS, Coffman JD, Balodimos MC, Koncz L, Soeldner JS: Capillary permeability and blood flow in skeletal muscle of patients with diabetes mellitus and genetic prediabetes. N Engl J Med 286:454-460, 1972
5. Jaap AJ, Shore AC, Tooke JE: Differences in microvascular fluid permeability between long-duration type I (insulin-dependent) diabetic patients with and without significant microangiopathy. Clin Sci 90:113-116, 1996
6. Wardle EN: Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract 23:135-139, 1994
7. Parving H-H, Rossing N: Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and long-term juvenile diabetic subjects. Scand J Clin Lab Invest 32:239-244, 1973
8. Tooke JE: Microvasculature in diabetes. Cardiovasc Res 32:764-771, 1996
9. Svensjö E, Arfors K-E, Raymond RM, Grega GJ: Morphological and physiological correlation of bradykinin-induced macromolecular efflux. Am J Physiol Heart Circ Physiol 5:H600-H606, 1979
10. Mayhan WG: Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol Heart Circ Physiol 266:H2369-H2373, 1994
11. Ialenti A, Ignaro A, Moncada S, Di Rosa M: Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 211:177-182, 1992
12. Ramírez MM, Kim DD, Durán WN: Protein kinase C modulates microvascular permeability through nitric oxide synthase. Am J Physiol Heart Circ Physiol 271:H1702-H1705, 1996
13. Schmidt A-M, Hori O, Brett J. Yan SD, Wautier J-L, Stern D: Cellular receptors for advanced glycation end products: implication for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 14:1521-1528, 1994
14. Gugliucci A, Bendayan M: Reaction of advanced glycation endproducts with renal tissue from normal and streptozotocin-induced diabetic rats: an ultrastructural study using colloidal gold cytochemistry. J Histochem Cytochem 43:591-600, 1995
15. Schmidt A-M, Yan SD, Stern D: The dark side of glucose. Nat Med 1: 1002-1004, 1995
16. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-Mcintosh RP, Cooper ME: Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40:619-628, 1997
17. Yan SD, Stern D, Schmidt AM: What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur J Clin Invest 27:179-181, 1997
18. Wautier J-L, Wautier M P, Schmidt AM, Anderson GM, Hori O, Zoukourian C, Capron L, Chappey O, Yan S-D, Brett J, Guillausseau PJ, Stern D: Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing vascular stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci U S A 91:7742-7746, 1994
19. Yan SD, Schmidt AM, Anderson GM, Zhang JH, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 299: 9889-9897, 1994
20. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
21. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
22. 2,-induced increase in endothelial permeability. Am J Physiol Lung Cell Mol Physiol 270:L973-L978, 1996
23. Wautier J-L, Zoukourian C, Chappey O, Wautier M-P, Guillausseau PJ, Cao R, Hori O, Stern D, Schmidt AM: Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J Clin Invest 97:238-243, 1996
24. Vicaut K, Stücker O: An intact cremaster muscle preparation for studying the microcirculation by in vivo microscopy. Microvasc Res 39:120-122, 1990
25. Laux V, Seiffge D: Mediator-induced changes in macromolecular permeability in the rat mesenteric microcirculation. Microvasc Res 49:117-133, 1995
26. Renard C, Chappey O, Wautier M P, Nagashima M, Lundh E, Morser J, Zhao L, Schmidt A-M, Scherrmann J-M, Wautier J-L: Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic rats. Mol Pharmacol 52:54-62, 1997
27. Sexton WL: Skeletal muscle vascular transport capacity in diabetic rats. Diabetes 43:225-231, 1994
28. Sexton WL, poole DC, Mathieu-Costello O: Microcirculatory structure-function relationships in skeletal muscle of diabetic rats. Am J Physiol Heart Circ Physiol 266:H1502-H1511, 1994
29. Leinonen H, Matikainen E, Juntunen J: Permeability and morphology of skeletal muscle capillaries in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 22:158-162, 1982
30. Bohlen HG, Niggl BA: Early arteriolar disturbances following streptozotocin-induced diabetes mellitus in adult mice. Microvasc Res 20; 19-29, 1980
31. Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15:1835-1843, 1992
32. Shasby DM, Lind SE, Shasby SS, Goldsmith JC, Hunninghake GW: Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood 65:605-614, 1985
33. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
34. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol Heart Circ Physiol 262:H611-H616, 1992
35. Oliver JA: Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 151:506-511, 1992
36. Jahr J, Grande PO: In vivo effects of tumor necrosis factor-a on capillary permeability and vascular tone in a skeletal muscle. Acta Anaesthesiol Scand 40:256-261, 1996
37. Sims DE, Miller FN, Donald A, Home MM, Edwards MJ: Interleukin-2 alters the positions of capillary and venule pericytes in rat cremaster muscle. J Submicrosc Cytol Pathol 26:507-513, 1994
38. Mayhan WG: Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 16:295-305, 1992